Haemonetics Corporation
- Industry Medical Instruments & Supplies
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
The Global Leader in Blood Management Solutions. Our comprehensive portfolio of devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain — from plasma and blood collectors to hos
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
HAE
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Haemonetics beats Q3 top and bottom line estimates, updates guidance
- Haemonetics Q3 2024 Earnings Preview
- Oppenheimer's Buy vs. Sell ideas paired by each SMID sector
- Top buy and top sell ideas in each sector – Oppenheimer
- Haemonetics Non-GAAP EPS of $0.99 beats by $0.10, revenue of $318M beats by $4.9M
- Haemonetics Q2 2024 Earnings Preview
- Haemonetics to acquire OpSens in an all-cash deal
- Citi opens upside catalyst watch for Haemonetics ahead of earnings report
- Haemonetics Non-GAAP EPS of $1.05 beats by $0.32, revenue of $311.3M beats by $18.61M
- Haemonetics Q1 2024 Earnings Preview
- Haemonetics wins FDA nod to advanced NexSys PCS plasma collection system
- Haemonetics Non-GAAP EPS of $0.77 beats by $0.07, revenue of $304M beats by $13.21M
- Haemonetics Q4 2023 Earnings Preview
- Stock picks de-risked from earnings from UBS
- Haemonetics sheds the most in over a year after earnings
- Haemonetics Non-GAAP EPS of $0.85 beats by $0.03, revenue of $305.3M beats by $4.83M
- Haemonetics Q3 2023 Earnings Preview
- Haemonetics Non-GAAP EPS of $0.83 beats by $0.16, revenue of $297.48M beats by $28.26M
- Haemonetics Q2 2023 Earnings Preview
- Haemonetics reaches new 52-week high; shares up 41% YTD
